Organon & Co.
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
OGN$13.89+0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Income
($ in millions except shares in thousands and per share amounts)
| Year EndedDecember 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Revenues | $6,263 | $6,174 | $6,304 |
| Costs, Expenses and Other | |||
| Cost of sales | 2,515 | 2,294 | 2,382 |
| Selling, general and administrative | 1,893 | 1,704 | 1,668 |
| Research and development | 528 | 471 | 339 |
| Acquired in-process research and development and milestones | 8 | 107 | 104 |
| Restructuring costs | 62 | 28 | 3 |
| Interest expense | 527 | 422 | 258 |
| Exchange losses | 42 | 11 | 4 |
| Other expense, net | 15 | 15 | 17 |
| 5,590 | 5,052 | 4,775 | |
| Income Before Income Taxes | 673 | 1,122 | 1,529 |
| Taxes on income | (350) | 205 | 178 |
| Net Income From Continuing Operations | 1,023 | 917 | 1,351 |
| Loss From Discontinued Operations - Net of Tax | — | — | — |
| Net Income | $1,023 | $917 | $1,351 |
| Earnings per Share - Basic: | |||
| Continuing operations | $4.01 | $3.61 | $5.33 |
| Discontinued operations | — | — | — |
| Net Earnings per Share - Basic | $4.01 | $3.61 | $5.33 |
| Earnings per Share - Diluted: | |||
| Continuing operations | $3.99 | $3.59 | $5.31 |
| Discontinued operations | — | — | — |
| Net Earnings per Share - Diluted | $3.99 | $3.59 | $5.31 |
| Weighted Average Shares Outstanding: | |||
| Basic | 255,239 | 254,082 | 253,538 |
| Diluted | 256,270 | 255,169 | 254,193 |
-54-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.